Current Topics in Complement II /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2008.
|
| Edición: | 1st ed. 2008. |
| Colección: | Advances in Experimental Medicine and Biology,
632 |
| Materias: |
Tabla de Contenidos:
- Adipokines and the Immune System: An Adipocentric View
- The Role of Complement in Stroke Therapy
- Food Intake Regulation by Central Complement System
- A Pivotal Role of Activation of Complement Cascade (CC) in Mobilization of Hematopoietic Stem/Progenitor Cells (HSPC)
- Regulation of Tissue Inflammation by Thrombin-Activatable Carboxypeptidase B (or TAFI)
- Interaction Between the Coagulation and Complement System
- Platelet Mediated Complement Activation
- Adrenergic Regulation of Complement-Induced Acute Lung Injury
- Ficolins: Structure, Function and Associated Diseases
- Complement Factor H: Using Atomic Resolution Structure to Illuminate Disease Mechanisms
- Role of Complement in Motor Neuron Disease: Animal Models and Therapeutic Potential of Complement Inhibitors
- The Role of Membrane Complement Regulatory Proteins in Cancer Immunotherapy
- Role of Complement in Ethanol-Induced Liver Injury
- Immune Complex-Mediated Cytokine Production is Regulated by Classical Complement Activation both In Vivo and In Vitro
- Subversion of Innate Immunity by Periodontopathic Bacteria via Exploitation of Complement Receptor-3
- Staphylococcal Complement Inhibitors: Biological Functions, Recognition of Complement Components, and Potential Therapeutic Implications
- Human Astrovirus Coat Protein: A Novel C1 Inhibitor
- Hypothesis: Combined Inhibition of Complement and CD14 as Treatment Regimen to Attenuate the Inflammatory Response
- Targeting Classical Complement Pathway to Treat Complement Mediated Autoimmune Diseases
- Compstatin: A Complement Inhibitor on its Way to Clinical Application
- Derivatives of Human Complement Component C3 for Therapeutic Complement Depletion: A Novel Class of Therapeutic Agents.